HFSH-β- (33-53) (TFA)

O=C([C@H]1N(CCC1)C([C@H](CC(O)=O)NC([C@H](CCCCN)NC([C@@H](NC([C@H](C(C)C)NC([C@H](CC(C)C)NC([C@H](CC(O)=O)NC([C@H](CCCNC(N)=N)NC([C@H]([C@H](O)C)NC([C@@H](N)CC2=CC=C(C=C2)O)=O)=O)=O)=O)=O)=O)CC3=CC=C(C=C3)O)=O)=O)=O)N[C@@H](C)C(N[C@@H](CCCNC(N)=N)C(N4[C@@H](CCC4)C(N[C@@H](CCCCN)C(N[C@@H]([C@@H](C)CC)C(N[C@@H](CCC(N)=O)C(N[C@@H](CCCCN)C(N[C@@H]([C@H](O)C)C(N[C@@H](CS)C(N[C@@H]([C@H](O)C)C(N[C@H](C(O)=O)CC5=CC=CC=C5)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O.OC(C(F)(F)F)=O

[1]Grasso P, et al. A synthetic peptide corresponding to hFSH-beta- (81-95) has thioredoxin-like activity. Mol Cell Endocrinol. 1991;78 (3) :163-170. |[2]Xu Y, et al. Pilot study of a novel (18) F-labeled FSHR probe for tumor imaging. Mol Imaging Biol. 2014;16 (4) :578-585. |[3]Santa-Coloma TA, et al. Serine analogues of hFSH-beta- (33-53) and hFSH-beta- (81-95) inhibit hFSH binding to receptor. Biochem Biophys Res Commun. 1992;184 (3) :1273-1279.